NEW YORK (360Dx) – Ortho Clinical Diagnostics said today that the China Food and Drug Administration has granted approval of its Ortho Vision platform of fully automated blood analyzers for low-, mid-, and high-volume transfusion medicine laboratories. The platform consists of Ortho Vison and Ortho Vision Max. Following the approval, the Ortho Vision platform is now commercially available in China. 

The instruments have been commercially available in other various locations around the world, including in the US and Europe, the firm said.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.